NSRX – nasus pharma ltd. ordinary shares (US:NASDAQ)
Stock Stats
News
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold [Yahoo! Finance]
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing [Yahoo! Finance]
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th [Yahoo! Finance]
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
Form 6-K Nasus Pharma Ltd For: Mar 16
Form EFFECT Nasus Pharma Ltd
Form 6-K Nasus Pharma Ltd For: Mar 06
Form 6-K Nasus Pharma Ltd For: Mar 04
Form F-1 Nasus Pharma Ltd
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.